Release Date: 05/07/16 09:49 Summary: Letter to Shareholders-DSH.AX Price Sensitive: No Download Document 208.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%